LS-C99755

antibody from LSBio

Targeting: MAP3K8 c-COT, COT, EST, ESTF, MEKK8, Tpl-2

Western blot

Antibody data

Submit

Validation data

Product number: LS-C99755 - Provider product page
Provider: LSBio
Proper citation: LifeSpan Cat#LS-C99755, RRID:AB_2297370
Product name: MAP3K8 / TPL2 Antibody (aa368-397) LS-C99755
Antibody type: Polyclonal
Description: Ammonium sulfate precipitation
Reactivity: Human
Host: Rabbit
Storage: Maintain refrigerated at 2°C to 8°C for up to 6 months. For long term storage store at -20°C.

MAP3K8 protein structure - LS-C99755 shown in red.

Enhanced validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Enhanced validation

Submitted by: LSBio (provider)
Enhanced method: Genetic validation
Main image
Experimental details: Formalin-fixed and paraffin-embedded human breast carcinoma tissue reacted with COT Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.

Supportive validation

Submitted by: LSBio (provider)
Main image
Experimental details: Formalin-fixed and paraffin-embedded human breast carcinoma tissue reacted with COT Antibody , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.